BUSINESS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited - About the Company
Glenmark Pharmaceuticals Ltd. is a research-oriented, worldwide, and incorporated pharmaceutical firm. It is a major player in the detection of new particles in the segments of new biological entity (NBEs) and new chemical entity (NCEs).
Glenmark Pharmaceuticals Ltd. has a considerable existence in acknowledged standard drug markets all over the developing countries entailing India. Its ancillary, Glenmark Generics Limited, too has a rapidly developing and powerful US standard drug market presence. The subordinate is also involved in trading APIs to monitored and partially monitored nations. Glenmark offers job prospects to more than 6000 individuals in over 80 nations. Moreover, it also takes pride of its 12 production units based in 4 nations and of its 5 Research & Development hubs.
The firm was selected as the top most Pharma firm in the world in the section of Small and Medium sized enterprise, besides being felicitated with best firm across developing markets by SCRIP in 2008. Another premiere global magazine, Forbes, identified Glenmark as the “Best under a Billion Dollar firms in Asia” in 2008.
Glenmark Pharmaceuticals Limited - Achievements
Some of the major achievements of Glenmark Pharmaceuticals Limited are described as below:
In 2009, the company was recognized as “India’s Most Innovative Firm” by Thomas Reuters in Life Sciences
In 2008, the firm was felicitated with “India’s Best Mid-Cap” firm award in 2008 by Finance Asia, which is Asia’s best finance periodical
In 2007, the company was identified as “Emerging firm of the year” for Business Excellence by Economic Times in the year 2007
In 2007, it won NDTV Profit felicitation in the class of “Best Value Developer
Glenmark Pharmaceuticals Limited - Products
Some of the Bulk Drugs and Intermediates manufactured by Glenmark Pharmaceuticals Ltd are mentioned as below:
Telimisrtan
Dihydro Chloride
Lercanidipine Hydrochloride
Paracoxib Sodium
Adapalene
Mupirocin Calcium Dehydrate
Valdecoxib
Glimipride
Nateglinide
Itra Conozole
Amiiodarone hydrocholride
Levo Cetrizine
Rosiglitazone Maleate
Desloratadine
Iron Polymaltose Complex
Bromo Benzoic Acid
Amiodarone
Esomerprazole Magnisium Trihydrate
Cilostazol
Perindropil Erbumine
Linezolid
Mosafride
Citrate
Glenmark Pharmaceuticals Limited - Financials
The financial details of Glenmark Pharmaceuticals Limited as on March 31, 2010 against March 31, 2009 are mentioned as under:
Figures ` in Lakhs
Glenmark Pharmaceuticals Limited - Contact Details
Glenmark Pharmaceuticals Limited
Glenmark House,
B D S Marg,
Chakala, Off Western Express Highway
Andheri (E), Mumbai - 400099
Tel: +91 22 4018 9999
Fax: +91 22 4018 9990
Email: [email protected]
Last updated on April 17, 2026
Glenmark Pharmaceuticals Ltd. is a research-oriented, worldwide, and incorporated pharmaceutical firm. It is a major player in the detection of new particles in the segments of new biological entity (NBEs) and new chemical entity (NCEs).
Glenmark Pharmaceuticals Ltd. has a considerable existence in acknowledged standard drug markets all over the developing countries entailing India. Its ancillary, Glenmark Generics Limited, too has a rapidly developing and powerful US standard drug market presence. The subordinate is also involved in trading APIs to monitored and partially monitored nations. Glenmark offers job prospects to more than 6000 individuals in over 80 nations. Moreover, it also takes pride of its 12 production units based in 4 nations and of its 5 Research & Development hubs.
The firm was selected as the top most Pharma firm in the world in the section of Small and Medium sized enterprise, besides being felicitated with best firm across developing markets by SCRIP in 2008. Another premiere global magazine, Forbes, identified Glenmark as the “Best under a Billion Dollar firms in Asia” in 2008.
Glenmark Pharmaceuticals Limited - Achievements
Some of the major achievements of Glenmark Pharmaceuticals Limited are described as below:
Glenmark Pharmaceuticals Limited - Products
Some of the Bulk Drugs and Intermediates manufactured by Glenmark Pharmaceuticals Ltd are mentioned as below:
Glenmark Pharmaceuticals Limited - Financials
The financial details of Glenmark Pharmaceuticals Limited as on March 31, 2010 against March 31, 2009 are mentioned as under:
| As on March 31, 2010 | As on March 31, 2009 | |
| Total Income | 102,278.18 | 85,610.59 |
| Total Expenditure | 87,992.80 | 65,327.51 |
| Revenues from Operations before Other Earnings |
14,285.38 | 20,283.08 |
| Other Income | 831.84 | 9,867.77 |
| Profit before Interest & Exceptional Items | 15,117.22 | 30,150.85 |
| Interest | 3,015.84 | 5,513.86 |
| Tax Expenses | 744.94 | 2814.56 |
| Paid-up Equity Share Capital | 2,698.38 | 2,505.20 |
| Net Sales | 102,191.05 | 85,529.13 |
| Other Operating Income | 87.13 | 81.46 |
Glenmark Pharmaceuticals Limited - Contact Details
Glenmark Pharmaceuticals Limited
Glenmark House,
B D S Marg,
Chakala, Off Western Express Highway
Andheri (E), Mumbai - 400099
Tel: +91 22 4018 9999
Fax: +91 22 4018 9990
Email: [email protected]
Last updated on April 17, 2026
